EP3774720A1 - Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren - Google Patents
Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäurenInfo
- Publication number
- EP3774720A1 EP3774720A1 EP19785180.1A EP19785180A EP3774720A1 EP 3774720 A1 EP3774720 A1 EP 3774720A1 EP 19785180 A EP19785180 A EP 19785180A EP 3774720 A1 EP3774720 A1 EP 3774720A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- group
- alkyl
- dicarbonyl intermediate
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000008206 alpha-amino acids Nutrition 0.000 title abstract description 3
- 238000005576 amination reaction Methods 0.000 title description 9
- 150000001728 carbonyl compounds Chemical class 0.000 title description 3
- 230000018044 dehydration Effects 0.000 title description 3
- 238000006297 dehydration reaction Methods 0.000 title description 3
- 150000001371 alpha-amino acids Chemical class 0.000 title description 2
- 125000004989 dicarbonyl group Chemical group 0.000 claims abstract description 66
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000007858 starting material Substances 0.000 claims abstract description 43
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 42
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 27
- 150000007942 carboxylates Chemical class 0.000 claims abstract description 15
- -1 hydroxy-substituted carbon atoms Chemical group 0.000 claims abstract description 14
- 230000002194 synthesizing effect Effects 0.000 claims abstract description 12
- 230000009466 transformation Effects 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 63
- 239000003054 catalyst Substances 0.000 claims description 49
- 238000005336 cracking Methods 0.000 claims description 47
- 239000011541 reaction mixture Substances 0.000 claims description 38
- 229910052799 carbon Inorganic materials 0.000 claims description 28
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 28
- 125000003545 alkoxy group Chemical group 0.000 claims description 27
- 238000005984 hydrogenation reaction Methods 0.000 claims description 27
- 229910052707 ruthenium Inorganic materials 0.000 claims description 24
- 125000004181 carboxyalkyl group Chemical group 0.000 claims description 23
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 23
- 125000001424 substituent group Chemical group 0.000 claims description 22
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 20
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 19
- 229910052739 hydrogen Inorganic materials 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 17
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 13
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 13
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 11
- JPIJQSOTBSSVTP-PWNYCUMCSA-N D-erythronic acid Chemical compound OC[C@@H](O)[C@@H](O)C(O)=O JPIJQSOTBSSVTP-PWNYCUMCSA-N 0.000 claims description 8
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 claims description 7
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 7
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 claims description 7
- 150000003863 ammonium salts Chemical class 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 150000001735 carboxylic acids Chemical class 0.000 claims description 6
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 claims description 6
- 229910052721 tungsten Inorganic materials 0.000 claims description 6
- 239000010937 tungsten Substances 0.000 claims description 6
- VQUZNVATTCZTQO-UHFFFAOYSA-N 2,3,4-trihydroxy-5-oxopentanoic acid Chemical compound O=CC(O)C(O)C(O)C(O)=O VQUZNVATTCZTQO-UHFFFAOYSA-N 0.000 claims description 4
- JYPFTOPPKDHQEW-UHFFFAOYSA-N 2,3-dihydroxy-4-oxobutanoic acid Chemical compound O=CC(O)C(O)C(O)=O JYPFTOPPKDHQEW-UHFFFAOYSA-N 0.000 claims description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 229940050410 gluconate Drugs 0.000 claims description 4
- DSLZVSRJTYRBFB-LLEIAEIESA-L D-glucarate(2-) Chemical compound [O-]C(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O DSLZVSRJTYRBFB-LLEIAEIESA-L 0.000 claims description 3
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 3
- 229930182817 methionine Natural products 0.000 claims description 3
- 229910052750 molybdenum Inorganic materials 0.000 claims description 3
- 239000011733 molybdenum Substances 0.000 claims description 3
- 229910052720 vanadium Inorganic materials 0.000 claims description 3
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 claims description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-M 2,3,4,5-tetrahydroxy-6-oxohexanoate Chemical compound O=CC(O)C(O)C(O)C(O)C([O-])=O IAJILQKETJEXLJ-UHFFFAOYSA-M 0.000 claims description 2
- QXKAIJAYHKCRRA-UHFFFAOYSA-M 2,3,4,5-tetrahydroxypentanoate Chemical compound OCC(O)C(O)C(O)C([O-])=O QXKAIJAYHKCRRA-UHFFFAOYSA-M 0.000 claims description 2
- NPTTZSYLTYJCPR-UHFFFAOYSA-L 2,3,4-trihydroxypentanedioate Chemical compound [O-]C(=O)C(O)C(O)C(O)C([O-])=O NPTTZSYLTYJCPR-UHFFFAOYSA-L 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims 4
- RBNPOMFGQQGHHO-UHFFFAOYSA-M glycerate Chemical compound OCC(O)C([O-])=O RBNPOMFGQQGHHO-UHFFFAOYSA-M 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 5
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 2
- 229940024606 amino acid Drugs 0.000 description 71
- 238000006243 chemical reaction Methods 0.000 description 59
- 150000001875 compounds Chemical class 0.000 description 50
- 239000000758 substrate Substances 0.000 description 48
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 43
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 25
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 24
- 235000004279 alanine Nutrition 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 22
- 125000001589 carboacyl group Chemical group 0.000 description 22
- 239000000174 gluconic acid Substances 0.000 description 21
- 235000012208 gluconic acid Nutrition 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 21
- 150000003839 salts Chemical group 0.000 description 18
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 17
- LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 16
- 238000001308 synthesis method Methods 0.000 description 16
- 241000894007 species Species 0.000 description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 235000001014 amino acid Nutrition 0.000 description 13
- 229910052751 metal Inorganic materials 0.000 description 13
- 239000002184 metal Substances 0.000 description 13
- 235000011114 ammonium hydroxide Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 10
- 230000037361 pathway Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- DSLZVSRJTYRBFB-LLEIAEIESA-N D-glucaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O DSLZVSRJTYRBFB-LLEIAEIESA-N 0.000 description 8
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical group OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 8
- 150000001299 aldehydes Chemical class 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 229940107700 pyruvic acid Drugs 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- JPIJQSOTBSSVTP-UHFFFAOYSA-N 2,3,4-trihydroxybutanoic acid Chemical compound OCC(O)C(O)C(O)=O JPIJQSOTBSSVTP-UHFFFAOYSA-N 0.000 description 6
- 239000000908 ammonium hydroxide Substances 0.000 description 6
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 6
- 150000002739 metals Chemical class 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- 150000001721 carbon Chemical group 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940126062 Compound A Drugs 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000002243 precursor Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000011975 tartaric acid Substances 0.000 description 4
- 235000002906 tartaric acid Nutrition 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- DSLZVSRJTYRBFB-UHFFFAOYSA-N d-glucaric acid Chemical compound OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NPTTZSYLTYJCPR-UHFFFAOYSA-N 2,3,4-trihydroxypentanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)C(O)=O NPTTZSYLTYJCPR-UHFFFAOYSA-N 0.000 description 2
- WQVXMLWFVLQPOR-UHFFFAOYSA-N 2-amino-4,5,6-trihydroxyhexanoic acid Chemical compound OC(=O)C(N)CC(O)C(O)CO WQVXMLWFVLQPOR-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RBNPOMFGQQGHHO-UWTATZPHSA-N D-glyceric acid Chemical compound OC[C@@H](O)C(O)=O RBNPOMFGQQGHHO-UWTATZPHSA-N 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 239000012084 conversion product Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N hydron;2,3,4,5-tetrahydroxy-6-oxohexanoate Chemical compound O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- QXKAIJAYHKCRRA-UHFFFAOYSA-N l-lyxonate Chemical compound OCC(O)C(O)C(O)C(O)=O QXKAIJAYHKCRRA-UHFFFAOYSA-N 0.000 description 2
- 239000000395 magnesium oxide Substances 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical class CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229940076788 pyruvate Drugs 0.000 description 2
- UPMFZISCCZSDND-JJKGCWMISA-M sodium gluconate Chemical compound [Na+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O UPMFZISCCZSDND-JJKGCWMISA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 2
- PBYZMCDFOULPGH-UHFFFAOYSA-N tungstate Chemical compound [O-][W]([O-])(=O)=O PBYZMCDFOULPGH-UHFFFAOYSA-N 0.000 description 2
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-L 2,3,4,5-tetrahydroxyhexanedioate Chemical compound [O-]C(=O)C(O)C(O)C(O)C(O)C([O-])=O DSLZVSRJTYRBFB-UHFFFAOYSA-L 0.000 description 1
- WPAMZTWLKIDIOP-WVZVXSGGSA-N 2-dehydro-3-deoxy-D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)CC(=O)C(O)=O WPAMZTWLKIDIOP-WVZVXSGGSA-N 0.000 description 1
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 1
- WPAMZTWLKIDIOP-UHFFFAOYSA-N 4,5,6-trihydroxy-2-oxohexanoic acid Chemical compound OCC(O)C(O)CC(=O)C(O)=O WPAMZTWLKIDIOP-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 238000005705 Cannizzaro reaction Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- APTGJECXMIKIET-WOSSHHRXSA-N Norethindrone enanthate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)CCCCCC)[C@@]1(C)CC2 APTGJECXMIKIET-WOSSHHRXSA-N 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical class NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 159000000007 calcium salts Chemical group 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- XAYGUHUYDMLJJV-UHFFFAOYSA-Z decaazanium;dioxido(dioxo)tungsten;hydron;trioxotungsten Chemical class [H+].[H+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O.[O-][W]([O-])(=O)=O XAYGUHUYDMLJJV-UHFFFAOYSA-Z 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000003821 enantio-separation Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000007871 hydride transfer reaction Methods 0.000 description 1
- 125000001183 hydrocarbyl group Chemical group 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- ALTWGIIQPLQAAM-UHFFFAOYSA-N metavanadate Chemical class [O-][V](=O)=O ALTWGIIQPLQAAM-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003152 propanolamines Chemical class 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- LSGOVYNHVSXFFJ-UHFFFAOYSA-N vanadate(3-) Chemical class [O-][V]([O-])([O-])=O LSGOVYNHVSXFFJ-UHFFFAOYSA-N 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/04—Formation of amino groups in compounds containing carboxyl groups
- C07C227/06—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
- C07C227/08—Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/46—Ruthenium, rhodium, osmium or iridium
- B01J23/462—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
- B01J23/56—Platinum group metals
- B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
- B01J23/652—Chromium, molybdenum or tungsten
- B01J23/6527—Tungsten
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J21/00—Catalysts comprising the elements, oxides, or hydroxides of magnesium, boron, aluminium, carbon, silicon, titanium, zirconium, or hafnium
- B01J21/18—Carbon
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
- C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
- C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/02—Preparation of carboxylic acids or their salts, halides or anhydrides from salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/373—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in doubly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
Definitions
- the present invention relates to synthesis methods for a-amino acids and a-amino acid derivatives, from a-, b-dihydroxy carbonyl starting compounds, including a-, b-dihydroxy carboxylic acids and carboxylates such as products obtained from glucose.
- Amino acids are the building blocks for protein synthesis and have a number of commercial uses, particularly as nutritional supplements.
- One important application resides in the use of amino acids as additives of animal feeds. This is due to the low levels, or in some cases the complete lack, of certain essential amino acids in the primary constituents of such feeds, such as soybeans.
- Amino acids are currently indispensable ingredients for improving the efficiency in the natural (biological) production of animal protein (e.g., in the form of meat and milk), and for generally increasing the overall supply of such high value protein.
- aspects of the invention are associated with the discovery of amino acid synthesis methods that can utilize substrates such as gluconic acid and glucaric acid, which are readily derived, for example from the oxidation of glucose.
- substrates such as gluconic acid and glucaric acid
- they may potentially exhibit greater stability compared to their precursor aldehydes (e.g., glucose). Under high temperature reaction conditions, this stability can lead to increased reaction selectivity and yield along a desired reaction sequence leading to the production of one or more defined amino acids. Product losses due to undesired side reactions are thereby reduced.
- FIG. 6 Further aspects relate to optional synthesis pathways that utilize a cracking step, resulting in an a-amino acid having a lower number of carbon atoms, relative to the substrate and/or precursor of this substrate.
- This cracking can be regulated by the use of a cracking catalyst or promoter, as well as reaction conditions, as described herein.
- the extent of cracking can thereby determine the relative yields of (i) same carbon atom-numbered a-amino acids relative to the substrate (i.e.. obtained without intermediate cracking), and (ii) lower carbon atom-numbered a-amino acids relative to the substrate (i.e.. obtained with intermediate cracking).
- More particular aspects relate to the discovery of synthesis pathways, or individual reaction steps of such pathways, which may be performed non-enzymatically, meaning without the use of an enzyme (e.g.. a polypeptide) in the reaction mixture.
- an enzyme e.g.. a polypeptide
- advantages reside in terms of allowing a wider range of possible reaction conditions, such as conditions of temperature and/or pH that would be detrimental to biological agents (e.g., would denature proteins including enzymes) but that nonetheless allow high productivities of a desired intermediate and/or end product.
- At least one of the synthesis steps described herein of (i) dehydrating the starting compound to form the dicarbonyl intermediate, (ii) cracking the dicarbonyl intermediate to form the cracked dicarbonyl intermediate, (iii) reductively aminating the dicarbonyl intermediate or the cracked dicarbonyl intermediate to produce the a-amino acid or a-amino acid derivative is a non-enzymatic reaction step (i.e. is not catalyzed using an enzyme).
- at least two of (i), (ii), and (iii) are non-enzymatic reaction steps, and more preferably all of (i), (ii), and (iii) are non-enzymatic reaction steps.
- representative methods comprise synthesizing 2-amino-3- deoxygluconic acid (2-amino-4,5,6-trihydroxyhexanoic acid) from gluconic acid or glucaric acid, synthesizing aspartic acid from tartaric acid, or synthesizing homoserine from erythronic acid.
- representative methods comprise synthesizing alanine from 4- , 5-, or 6-carbon atom-numbered substrates, for example gluconic acid or glucaric acid.
- the alanine may be obtained from a reaction pathway involving a variety of possible starting compounds, with cracking to form a pyruvic acid intermediate.
- this starting compound namely an a-, b-dihydroxy carbonyl compound, /. e..
- a general class of compounds that embraces a-, b-dihydroxy carboxylic acids and carboxylates is dehydrated to form a dicarbonyl intermediate by transformation of the a-hydroxy group to a second carbonyl group (adj acent a carbonyl group of the starting compound) and removal of the b-hydroxy group.
- the dicarbonyl intermediate is optionally cracked to form a second, in this case cracked, dicarbonyl intermediate having fewer carbon atoms relative to the dicarbonyl intermediate but preserving the first and second carbonyl groups.
- Either or both of the dicarbonyl intermediate and the cracked dicarbonyl intermediate are aminated (e.g , with gaseous ammonia, NEE, or aqueous ammonia, NH4OH), such that the second carbonyl group of the intermediate and/or cracked intermediate is converted to an amino (-NEE) group, to produce the a-amino acid(s).
- aminated e.g , with gaseous ammonia, NEE, or aqueous ammonia, NH4OH
- aminating agents such as substituted amines (e.g., alkylamines or dialkylamines), may likewise be used to alternatively convert the second carbonyl group to the corresponding, substituted amino group (e.g , alkylamino or dialky lamino), and thereby produce the corresponding a-amino acid derivative(s).
- substituted amines e.g., alkylamines or dialkylamines
- substituted amino group e.g , alkylamino or dialky lamino
- Figure 1 illustrates a general reaction mechanism, comprising steps for synthesizing a- amino acids according to synthesis methods described herein.
- Figure 2 illustrates a specific reaction mechanism, according to which gluconic acid is the starting material or substrate, with specific byproducts also shown.
- the term“substrate,” or alternatively,“starting compound,” refers to the initial compound that is subjected to one or preferably a series of conversion steps, such as “dehydrating,” optional“cracking,” and“aminating” conversion steps, to yield an a-amino acid or a-amino acid derivative. These conversion steps do not preclude the use of prior conversion steps, such as under the same reaction conditions (e.g., in the same reactor) or under different reaction conditions (e.g., in a separate reactor), as used to produce the a-amino acid or a-amino acid derivative.
- Such prior conversion steps can include the conversion of a readily available precursor, such as glucose, to gluconic acid or glucaric acid as the starting compound, such as by oxidation.
- a step of“producing the a-amino acid or a-amino acid derivative” does not preclude the use of subsequent conversion steps, such as under the same reaction conditions (e.g., in the same reactor) or under different reaction conditions (e.g., in a separate reactor), as used to produce the a-amino acid or a-amino acid derivative, to obtain one or more other desired end products.
- the a-amino acid produced by the series of conversion steps may be homoserine (having an a-amino acid side chain of-CTFEOH).
- the desired end product methionine (having an a-amino acid side chain of -C2H5SCH3) may be obtained, for example, by the subsequent chemical conversion of the homoserine in the presence of a mercaptan compound (e.g., methylmercaptan). Methods for this conversion also include known routes based on fermentation.
- a mercaptan compound e.g., methylmercaptan
- a-amino acid derivative of an a-amino acid refers to any chemical compound wherein the carboxylic acid substituent of that a-amino acid may be converted to, or has the corresponding chemical structure of, an ester, aldehyde or ketone and/or the primary amine substituent of that a-amino acid is converted to, or has the corresponding chemical structure of, a secondary or tertiary amine or is replaced by another substituent which can include hydroxy, halogen among others.
- mol-% and“wt-%” are used to designate amounts or concentrations in terms of percent by mole and percent by weight, respectively.
- Product yields given in terms of “mol-%” refer to the moles of a given product (e.g . , an a-amino acid such as alanine) obtained, based on the moles of substrate used (introduced or fed to the reactor).
- alkyl when used alone or in combination with other moieties, for example, when used in combination in “alkoxy,” “alkoxyalkyl,” “hydroxyalkyl,” “carboxyalkyl,” “alkanoyl,” and“alkanoyl alkyl,” represents a hydrocarbon moiety that is derived from an alkane.
- “alkyl” therefore includes“methyl” (CH 3 -),“ethyl” (C 2 H 5 -), etc.
- the alkyl portion of the moiety“alkoxy” is bonded at an end of the moiety to the rest of the molecule, through an intervening oxygen linkage, -0-, such as in the case of“methoxy” (CH 3 -O-),“ethoxy” (C 2 H 5 -O-), etc., which terms are encompassed by “alkoxy.”
- the term“hydroxy” represents the moiety -OH
- the term“hydroxyalkyl” represents hydroxy bonded at the end of the moiety to the rest of the molecule, through an intervening divalent alkyl portion, such as in the case of “hydroxymethyl” (HO-CH 2 -),“hydroxy ethyl” (HO-C 2 H 5 -), etc., which terms are encompassed by“hydroxyalkyl.”
- the term“alkoxyalkyl” includes both
- “alkoxyalkyl” encompasses “methoxymethyl” (CH 3 -O-CH 2 -), “methoxy ethyl” (CH 3 -O-C 2 H 4 -), “ethoxymethyl” (C 2 H 5 -O-CH 2 -), “ethoxyethyl” (C 2 H 5 -O-C 2 H 4 -), etc.
- alkanoylalkyl includes both a terminal alkanoyl portion (i.e..
- a terminal alkyl portion its terminal carbon atom may be substituted with two CTT substituents, to yield a terminal isopropyl moiety, or may be substituted with three CTT substituents, to yield a terminal t-butyl moiety.
- an intervening alkyl portion, or an intervening carbon atom of a terminal alkyl portion one or two hydrogen substituents at carbon-hydrogen bonds of an alkylene carbon atom may be substituted with - CTT substituents to yield the corresponding methyl-substituted or dimethyl-substituted derivatives.
- phrase“having from 1 to 5 carbon atoms,” and other phrases defining the number of alkyl carbon atoms refer to a backbone number of alkyl carbon atoms that may be further substituted with -CH3 substituents or other substituents, according to the specific definitions given.
- Carboxylic acid compounds including amino acids, include their corresponding salt forms.
- the salt form is normally used in aqueous solution for carrying out the synthesis methods described herein.
- Corresponding salt forms of carboxylic acid include, for example, salts of alkali metals (e.g., the sodium salt form), salts of alkaline earth metals (e.g, the calcium salt form), and ammonium salts.
- compounds such as“gluconic acid,”“glucaric acid,” “2-amino-3-deoxygluconic acid” (or “2-amino-4,5,6-trihydroxyhexanoic acid”), “aspartic acid,”“tartaric acid,”“homoserine,”“lactic acid,” etc. are meant to encompass salt forms of “gluconate,” “glucarate,” “2-amino-3-deoxy gluconate” (or “2-amino-4,5,6- trihydroxyhexanoate”),“aspartate,”“tartarate,”“homoserinate,”“lactate,” etc.
- the structure of alanine for example, when shown with these groups being un-ionized, is meant to encompass structures with one or both of these groups being ionized, with un-ionized and ionized amino and carboxyl groups of the equivalent structures of this compound shown below:
- “gluconic acid” is intended to encompass“gluconic acid and stereoisomers thereof,” as is intended with respect to other compounds designating a specific stereochemistry.
- Generic and specific compounds described herein may be used or obtained in the form of pure or purified (enriched) optical isomers or otherwise in the form of racemic mixtures thereof.
- optically active substrates or starting compounds will result in the formation of optically active products, including a-amino acids and a-amino acid derivatives, using the synthesis methods described herein, as would be appreciated by those having skill in the art, combined with knowledge from the present disclosure.
- the purification of a particular optical isomer, or enrichment in one optical isomer relative to another can be obtained, for example, by the formation of diastereomeric salts through treatment with an optically active acid or base.
- appropriate acids are tartaric, diacetyltartaric, dibenzoyltartaric, ditoluoyltartaric and camphorsulfonic acid.
- appropriate bases are plant-derived chiral alkaloids.
- the mixtures of diastereomers are then separated by crystallization, followed by liberation of the optically active bases or acids from these salts.
- a different process for separation of optical isomers involves the use of a chiral chromatography column chosen to maximize the separation of the enantiomers.
- Still another available method involves synthesis of covalent diastereomeric molecules by reaction with an optically pure acid in an activated form or an optically pure isocyanate.
- the synthesized diastereomers can be separated by conventional means such as chromatography, distillation, crystallization or sublimation, and then hydrolyzed to yield the enantiomerically pure compound.
- FIG. 1 A general reaction mechanism for synthesizing a-amino acids is illustrated in FIG. 1.
- a compound of general Formula I is a starting compound that is broadly an a-, b- dihydroxy carbonyl compound, which encompasses a preferred class of compounds, namely a-, b-dihydroxy carboxylic acid or carboxylate when R 1 is hydroxy (-OH) to provide a terminal carboxyl group on the left-hand side of the illustrated compound.
- a first step of dehydration causes removal of the b-hydroxy group, together with formation of a site of unsaturation, /. e.. a carbon-carbon double bond between the a-carbon atom and the b-carbon atom.
- the resulting ethylenically unsaturated, dehydrated compound, shown as compound A tends to maintain tautomeric equilibrium with the dicarbonyl intermediate shown as having general Formula IIA.
- the dehydrating step may therefore comprise forming water from a combination of the b-hydroxy group and hydrogen of the a-hydroxy group, in a starting compound or substrate of general Formula I.
- Animation of this dicarbonyl intermediate with an animating agent, or reductive aminating agent, of the formula NHR 3’ R 3" , as shown, can produce an a-amino acid or a-amino acid derivative having the general Formula IIIA
- FIG.1 which may be an a-amino acid, for example in the case of R 1 being hydroxy (-OH) and the aminating agent being gaseous or aqueous ammonia (ammonium hydroxide), such that R 3’ and R 3" are each hydrogen substituents.
- the compound above may be a particular a-amino acid derivative, having at least a derivatized amino group, in the case of other types of aminating agents, such as monoalkyl or dialkyl amines.
- methylamine as an aminating agent can result in the corresponding methylamino acid derivative, in which case one of R 3’ and R 3" may be a hydrogen substituent and the other a methyl substituent, and methylethylamine as an aminating agent can result in the corresponding methyl, ethyl diamino acid derivative, in which case one of R 3’ and R 3” may be a methyl substituent and the other an ethyl substituent.
- R 3’ and R 3 may be a hydrogen substituent and the other a methyl substituent
- methylethylamine as an aminating agent can result in the corresponding methyl, ethyl diamino acid derivative, in which case one of R 3’ and R 3” may be a methyl substituent and the other an ethyl substituent.
- the dicarbonyl intermediate compound of general Formula IIA may optionally undergo cracking to form the cracked dicarbonyl intermediate of general Formula IIB.
- the moiety represented by R 2B in the cracked dicarbonyl intermediate of general Formula IIB has fewer carbon atoms relative to the moiety represented by R 2A in the dicarbonyl intermediate of general Formula IIA.
- the cracked dicarbonyl intermediate overall has fewer carbon atoms relative to the dicarbonyl intermediate.
- Amination of the cracked dicarbonyl intermediate can then produce an a-amino acid or a-amino acid derivative having the general Formula IIIB
- this second cracked species may have the structure according to compound B, as shown and having an aldehyde group.
- this second cracked species may include other functional groups, such as a carboxylic acid functional group, as the moiety represented by R 2C , or otherwise included in a terminal portion of this moiety, which is bonded to the aldehyde functional group.
- Such a second cracked species may result, for example, when the moiety represented by R 2A in the dicarbonyl intermediate of general Formula IIA is bonded through a hydroxy-substituted carbon atom.
- the second cracked species of compound B may result in the case of R 2A , or at least a terminal portion of R 2A , representing a moiety of
- the cracked dicarbonyl intermediate will have fewer carbon atoms, relative to both the dicarbonyl intermediate and the substrate.
- the cracked dicarbonyl intermediate may then become aminated, whereas further conversions of the second cracked species (e.g, by amination and/or hydrogenation) may form other desirable compounds, for example as described with respect to the more particular embodiment shown in FIG. 2.
- the moiety represented by R 2C in compound B may have one fewer carbon atom, relative to the moiety represented by R 2A , and compound B may represent a corresponding aldehyde formed from R 2A and having the same number of carbon atoms as R 2A .
- the cracked dicarbonyl intermediate may be pyruvic acid, which may become aminated to alanine.
- a synthesis route to alanine, through cracking of the dicarbonyl intermediate to form pyruvic acid can be carried out using a variety of a-, b- dihydroxy carbonyl compounds, including a-, b-dihydroxy carboxylic acids and carboxylates having at least four carbon atoms, as substrates.
- a 3 carbon atom-numbered a-amino acid such as alanine
- a 3 carbon atom-numbered a-amino acid may be produced from available 4-, 5-, or 6-carbon atom-numbered a-, b- dihydroxy carboxylic acids and carboxylates as starting compounds, such as erythronic acid (or 2,3,4-trihydroxybutanoic acid generally); 2,3-dihydroxy-4-oxobutanoic acid; tartaric acid; 2,3,4,5-tetrahydroxypentanoic acid; 2,3,4-trihydroxy-5-oxopentanoic acid; 2,3,4- trihydroxypentanedioic acid; gluconic acid (or 2,3,4,5,6-pentahydroxyhexanoic acid generally); 2,3,4,5-tetrahydroxy-6-oxohexanoic acid, and glucaric acid (or 2, 3,4,5- tetrahydroxyhexanedioic acid generally).
- a- amino acids or their derivatives having different numbers of carbon atoms, may be formed from a combination of both synthesis via a di carbonyl intermediate and synthesis via a cracked dicarbonyl intermediate, with relative yields of the different a-amino acids or their derivatives being regulated.
- all or substantially all (e.g., greater than 95 mol-%) of the a-amino acid or a-amino acid derivative produced according to the synthesis method may be via animation of the dicarbonyl intermediate of general Formula IIA, in which case this a-amino acid or a-amino acid derivative may have the same number of carbon atoms as the dicarbonyl intermediate, as well as the substrate.
- R 1 may be alkyl (e.g., having from 1 to 3 alkyl carbon atoms) and may result in a terminal ketone functional group in the respective compounds; R 1 may be alkoxy (e.g., having from 1 to 3 alkyl carbon atoms) and may result in a terminal ester functional group in the respective compounds; or R 1 may be hydroxy and may result in a terminal carboxyl functional group in the respective compounds.
- R 1 is hydroxy, whereby the starting compound and the dicarbonyl intermediate are carboxylic acids.
- the starting compound, the dicarbonyl intermediate, and the a-amino acid or a-amino acid derivative may be in the form of (e.g., present in the reaction mixture as) carboxylates, meaning compounds comprising a carboxylate anion and possibly present in salt form in an aqueous reaction mixture (e.g., in their corresponding ammonium salt form) that is used to carry out synthesis methods described herein.
- R 2A may selected from the group consisting of a hydrogen substituent, alkyl, alkoxy, hydroxy, hydroxyalkyl, carboxy, carboxyalkyl, alkanoyl, and alkanoylalkyl, wherein alkyl and the alkyl portions of alkoxy, alkoxyalkyl, hydroxyalkyl, carboxyalkyl, alkanoyl, and alkanoylalkyl have from 1 to 3 carbon atoms, optionally substituted with one or more of -OH and/or one or more of -CH3.
- R 2A may be a hydrogen substituent, alkyl, carboxy, carboxyalkyl, alkanoyl, or alkanoylalkyl, wherein alkyl and the alkyl portions of carboxyalkyl, alkanoyl, and alkanoylalkyl have from 1 to 3 carbons atoms, optionally substituted with one or more of -OH.
- Particular substrates having from 3-6 carbon atoms include 2,3-dihydroxy propanoic acid; erythronic acid (or 2,3,4-trihydroxybutanoic acid generally); 2,3-dihydroxy-4-oxobutanoic acid; tartaric acid; 2,3,4,5-tetrahydroxypentanoic acid; 2,3,4-trihydroxy-5-oxopentanoic acid; 2,3,4-trihydroxypentanedioic acid; gluconic acid (or 2,3,4,5,6-pentahydroxyhexanoic acid generally); 2,3,4,5-tetrahydroxy-6-oxohexanoic acid, and glucaric acid (or 2,3,4,5-tetrahydroxyhexanedioic acid generally).
- R 2A is a hydrogen substituent
- cracking to form a cracked dicarbonyl intermediate of general Formula IIB cannot occur.
- an a-amino acid or a-amino acid derivative may be produced from the dicarbonyl intermediate of general Formula IIA, for example in the production of alanine from 2-,3-dihydroxy propanoic acid, in the absence of cracking.
- R 2B may selected from the group consisting of a hydrogen substituent, alkyl, alkoxy, hydroxy, hydroxyalkyl, carboxy, carboxyalkyl, alkanoyl, and alkanoylalkyl, wherein alkyl and the alkyl portions of alkoxy, alkoxyalkyl, hydroxyalkyl, carboxyalkyl, alkanoyl, and alkanoylalkyl have from 1 to 3 carbon atoms, optionally substituted with one or more of -OH and/or one or more of -CH 3 .
- R 2B may be a hydrogen substituent, alkyl, carboxy, carboxyalkyl, alkanoyl, or alkanoylalkyl, wherein alkyl and the alkyl portions of carboxyalkyl, alkanoyl, and alkanoylalkyl have 1 or 2 carbons atoms, optionally substituted with one or more of -OH.
- R 2B may be a hydrogen substituent or alkyl having from 1 to 3 carbon atoms, optionally substituted with one or more of -OH.
- the cracked dicarbonyl intermediate is pyruvic acid that may become aminated to form alanine, potentially from a variety of possible a-, b-hydroxy carboxylate substrates, as described above.
- the second cracked species of compound B may result in the case of R 2A , or at least a terminal portion of R 2A , representing a moiety of Accordingly, R 2C in compounds having the general formula given for compound B may represent moieties as defined above with respect to R 2A , but having at least one fewer carbon atom.
- R 2C may selected from the group consisting of a hydrogen substituent, alkyl, alkoxy, hydroxy, hydroxyalkyl, carboxy, carboxyalkyl, alkanoyl, and alkanoylalkyl, wherein alkyl and the alkyl portions of alkoxy, alkoxyalkyl, hydroxyalkyl, carboxyalkyl, alkanoyl, and alkanoylalkyl have one or two carbon atoms, optionally substituted with one or more of -OH and/or one or more of -CH3.
- R 2C may be a hydrogen substituent or alkyl having one or two carbon atoms, optionally substituted with one or more of -OH.
- R 3’ and R 3” are independently a hydrogen substituent or alkyl having from 1 to 3 carbon atoms. More preferably, R 3’ and R 3" are independently a hydrogen substituent, methyl, or ethyl. Still more preferably R 3’ and R 3” are both a hydrogen substituent.
- a typical reaction environment associated with the synthesis of an a-amino acid or a- amino acid derivative, according to methods described herein, includes an elevated hydrogen partial pressure, such as a hydrogen partial pressure of at least 3 megapascals (MPa) (435 psi), optionally in combination with a hydrogenation catalyst.
- a hydrogen partial pressure such as a hydrogen partial pressure of at least 3 megapascals (MPa) (435 psi)
- MPa megapascals
- the terminal aldehyde group in the second cracked species of compound B may be converted to a terminal alcohol or hydroxy (-OH) group.
- FIG. 2 illustrates the synthesis method presented in FIG. 1, using gluconic acid (or generally 2,3,4,5,6-pentahydroxyhexanoic acid) as a starting compound, or compound of Formula I, in which R 2A represents the moiety
- the dicarbonyl intermediate of Formula IIA is 2-keto-3-deoxygluconic acid (2-keto-4,5,6-trihydroxyhexanoic acid), as shown.
- This dicarbonyl intermediate can then undergo amination with gaseous or aqueous ammonia to yield an a-amino acid, having the same number of carbon atoms relative to the starting compound.
- this a-amino acid is 2-amino-3-deoxy gluconic acid (2-amino-4,5,6-trihydroxyhexanoic acid), which is shown as the compound having Formula IIIA.
- the dicarbonyl intermediate can undergo cracking to yield a cracked dicarbonyl intermediate of Formula IIB, which in the embodiment illustrated in FIG. 2 is pyruvic acid. Amination of this cracked dicarbonyl intermediate then provides a pathway to a different a-amino acid, having fewer carbon atoms relative to the starting compound. In this case, this different a-amino acid is alanine, shown as the compound having Formula IIIB.
- cracking to form pyruvic acid additionally forms a second cracked species of compound B, in this case is glyceraldehyde, according to which R 2C in the general formula for this compound as shown in FIG. 1, is a moiety of
- glyceraldehyde the second cracked species of compound B, can undergo further reactions, such as those involving a 1, 2-hydride shift or a hydride transfer (Cannizzaro reaction) to cause its conversion to lactic acid, as shown in FIG. 2.
- glyceraldehyde can combine with alanine to form an alanine/glyceraldehyde dimer, as also shown.
- alanine and lactic acid may be produced in a combined molar amount that exceeds a net molar amount of glyceraldehyde produced, despite the fact that the cracking reaction may yield equimolar amounts of pyruvic acid (which may become aminated to produce alanine or hydrogenated to produce lactic acid) and glyceraldehyde.
- the ratio of the combined molar amount of alanine and lactic acid to the net molar amount of glyceraldehyde e.g, in the reaction mixture after completion of a synthesis method
- This excess may result, at least in part, due to the conversion of glyceraldehyde to lactic acid.
- Representative synthesis methods therefore comprise reacting an a-, b-dihydroxy carboxylic acid or carboxylate starting compound in a reaction mixture, to form an a-amino acid or a-amino acid derivative having the same number of carbon atoms, relative to the starting compound, and/or to form an a-amino acid or a-amino acid derivative having fewer carbon atoms, relative to the starting compound.
- the reaction mixture preferably comprises a cracking catalyst or promoter of the reaction step shown as“optional cracking” in FIGS. 1 and 2.
- Preferred cracking catalysts comprise one or more cracking active metals, such as tungsten, molybdenum, and/or vanadium, which may be present in the form of corresponding salts in the reaction mixture, such as tungstate, molybdate, or vanadate salts, which include a metatungstate salt, a paratungstate salt, a metamolybdate salt, a paramolybdate salt, a metavanadate salt, or a paravanadate salt.
- Representative tungstate salts are salts of Group 1 (alkali) metals or Group 2 (alkaline earth) metals, as well as ammonium salts. Ammonium metatungstate and ammonium paratungstate salts are representative.
- a cracking catalyst e.g.
- ammonium metatungstate may be present in the reaction mixture in an amount of from 0.1 mol-% to 30 mol-%, from 0.5 mol-% to 10 mol-%, or from 1 mol-% to 5 mol-%, relative to the number of moles of substrate, for example according to the initial reactor loading composition in the case of a batchwise reaction or according to a steady-state composition in the case of a continuous reaction.
- the cracking catalyst may also, or may alternatively, be present in the reaction mixture in an amount such that the moles of cracking active metal (e.g., tungsten, molybdenum, or vanadium) may represent from 6 mol-% to 50 mol-%, or from 10 mol-% to 35 mol-%, relative to the number of moles of substrate.
- Other cracking catalysts can include solid acids and/or Lewis acids (e.g., organometallic compounds, including organotin compounds).
- particular methods comprise synthesizing alanine from an a-, b-dihydroxy carboxylate starting compound having greater than 3 carbon atoms, such as a salt of gluconate (or 2,3,4,5,6-pentahydroxyhexanoate generally); 2, 3,4,5- tetrahydroxy-6-oxohexanoate; glucarate (or 2,3,4,5-tetrahydroxyhexanedioate generally); 2,3,4,5-tetrahydroxypentanoate; 2,3,4-trihydroxy-5-oxopentanoate; 2,3,4- trihydroxypentanedioate; erythronate (or 2,3,4-trihydroxybutanoate generally); 2,3-dihydroxy- 4-oxobutanoate; or tartarate.
- a salt of gluconate or 2,3,4,5,6-pentahydroxyhexanoate generally
- 2, 3,4,5- tetrahydroxy-6-oxohexanoate glucarate (or 2,3,4,5-t
- such methods comprise dehydrating this starting compound to form a dicarbonyl intermediate by transformation of the alpha hydroxy group to a second carbonyl group and removal of the beta hydroxy group, and cracking this dicarbonyl intermediate to form pyruvate.
- the pyruvate is then aminated to produce the alanine.
- the cracking catalyst can be used to regulate the relative yields of (i) a-amino acids and/or a-amino acid derivatives having the same number of carbon atoms relative to the substrate and obtained from a synthesis pathway that does not include cracking and (ii) a-amino acids and/or a-amino acid derivatives having fewer carbon atoms relative to the substrate and obtained from a synthesis pathway that includes cracking.
- the yield(s) of a-amino acids and/or a-amino acid derivatives according to (i) above may account for at least 85 mol-%, or even at least 95 mol-%, of the molar yield(s) of all a-amino acids and/or a-amino acid derivatives produced.
- the molar yield(s) of a-amino acids and/or a-amino acid derivatives according to (ii) above may account for at least 50 mol-% (e.g, from 50 mol-% to 95 mol-%), or at least 75 mol-% (e.g, from 70 mol-% to 90 mol-%), of the molar yield(s) of all a-amino acids and/or a-amino acid derivatives produced.
- the total yield(s) of a-amino acids and/or a-amino acid derivatives according to (i) above and/or the total yield(s) of a-amino acids and/or a-amino acid derivatives according to (ii) above, based on the theoretical yields proceeding through the respective non-cracking pathway (i) or optional cracking pathway (ii), may be generally at least 25 mol-% (e.g, from 25 mol-% to 90 mol-%), typically at least 35 mol-% (e.g, from 35 mol- % to 80 mol-%), and often at least 50 mol-% (e.g, from 50 mol-% to 75 mol-%).
- yields can apply, for example, to any of the a-amino acids and/or a-amino acid derivatives according to general Formulas IIIA and IIIB described herein, including the specific a-amino acids and/or a-amino acid derivatives described herein (e.g., alanine) as products of the synthesis.
- the reaction mixture which is preferably an aqueous reaction mixture, may further comprise an aminating agent such as gaseous or aqueous ammonia (ammonium hydroxide) as described above, and/or otherwise possibly an alkylated amine such as a compound of the formula NHR 3’ R 3" , wherein R 3’ and R 3 are as defined herein, e.g., with respect to compounds according to Formula IIIA and IIIB.
- an aminating agent such as gaseous or aqueous ammonia (ammonium hydroxide) as described above, and/or otherwise possibly an alkylated amine such as a compound of the formula NHR 3’ R 3" , wherein R 3’ and R 3 are as defined herein, e.g., with respect to compounds according to Formula IIIA and IIIB.
- ammonium salts such as ammonium halides, may also be used in place of, or in combination with, ammonium hydroxide.
- ammonium salts e.g., ammonium hydroxide and/or ammonium chloride
- concentration, or combined concentration from 10 wt-% to 50 wt-%, or from 15 wt-% to 35 wt-%.
- amount of solution comprising such ammonium salt(s) is at least sufficient to solubilize the substrate, cracking catalyst (if used), and any additives, in an aqueous solution as the reaction mixture.
- the reaction mixture may further comprise a hydrogenation catalyst, such as solid (heterogeneous) catalyst.
- a representative hydrogenation catalyst may comprise one or more hydrogenation active metals selected from Groups 8-11 of the Periodic Table, such as, for example, ruthenium (Ru), cobalt (Co), nickel (Ni), platinum (Pt), palladium (Pd), or gold (Au).
- a preferred hydrogenation active metal is ruthenium.
- the catalyst may further comprise a solid support of the hydrogenation active metal(s), with the metals being dispersed on the solid support according to a distribution, for example preferentially near the outer surface of the solid support or otherwise substantially uniformly throughout a porous solid support, depending on the particular catalyst preparation technique used (e.g., evaporative impregnation of a solution of the hydrogenation active metal).
- the hydrogenation active metal, or such metals in combination is/are present in an amount from 1 wt-% to 15 wt-%, or from 2 wt-% to 10 wt- %, based on the total weight of the hydrogenation catalyst.
- the hydrogenation active metal(s) may also, or may alternatively, be present in the reaction mixture in an amount such that the moles of hydrogenation active metal(s) (e.g., ruthenium) represent from 1 mol-% to 20 mol-%, or from 2 mol-% to 10 mol-%, relative to the number of moles of substrate, for example according to the initial reactor loading composition in the case of a batchwise reaction or according to steady-state composition in the case of a continuous reaction.
- the solid support is preferably refractory in the reaction mixture and under the synthesis reaction conditions described herein.
- Representative solid supports comprise one or more metal oxides, such as aluminum oxide (alumina), silicon oxide (silica), titanium oxide (titania), zirconium oxide (zirconia), magnesium oxide (magnesia), strontium oxide (strontia), etc.
- a preferred solid support is carbon.
- the hydrogenation catalyst comprises ruthenium on a carbon support, with the ruthenium being present in an amount within a range given above, based on total catalyst weight and/or within a range given above, relative to the number of moles of substrate.
- Reaction conditions under which the reaction mixture is maintained during the synthesis of the a-amino acid and/or a-amino acid derivative, include an elevated pressure and hydrogen partial pressure.
- Representative absolute reactor pressures are in the range generally from 2.07 MPa (300 psi) to 24.1 MPa (3500 psi), typically from 3.45 MPa (500 psi) to 20.7 MPa (3000 psi), and often from 10.3 MPa (1500 psi) to 17.2 MPa (2500 psi).
- the reactor pressure may be generated predominantly or substantially from hydrogen, such that these ranges of total pressure may also correspond to ranges of hydrogen partial pressure.
- the presence of gaseous ammonia or other aminating agent, as well as other gaseous species vaporized from the reaction mixture, may result in the hydrogen partial pressure being reduced relative to these total pressures, such that, for example, the hydrogen partial pressure may range generally from 1.38 MPa (200 psi) to 22.4 MPa (3250 psi), typically from 2.41 MPa (350 psi) to 19.0 MPa (2750 psi), and often from 8.62 MPa (1250 psi) to 15.5 MPa (2250 psi).
- reaction conditions include a temperature from l00°C to 350°C, and preferably from l30°C to 230°C.
- the reaction time, /. e.. time at which the reaction mixture is maintained under conditions of pressure and temperature at any target values or target sub-ranges within any of the ranges of pressure and temperature given above e.g, a target, total pressure value of 13.8 MPa (2000 psi) and a target temperature of l60°C
- a target, total pressure value of 13.8 MPa (2000 psi) and a target temperature of l60°C is from 0.5 hours to 24 hours, and preferably from 1 hour to 5 hours, in the case of a batch wise reaction.
- these reaction times correspond to reactor residence times.
- Continuous operation may be performed, for example, under the conditions of pressure and temperature described above, with continuous feeding of the substrate, aminating agent, and hydrogen, and continuous withdrawal of the reaction mixture comprising the a-amino acid or a-amino acid derivative.
- Continuous operation may further include the continuous purification of the a-amino acid or a-amino acid derivative, the continuous separation of process streams comprising unconverted gaseous and/or liquid products, and/or the continuous recycle of one or more of such process streams back to the reaction mixture, maintained in the synthesis reactor.
- the yields of the a-amino acid or a-amino acid derivative, as described above will correspond to the“once-through” or“per-pass” yield, with higher overall yields being possible due to the recycle.
- Parr reactor was pressurized to below the target pressure of 13.8 MPa (2000 psi), and the reaction mixture was heated to a target temperature of 200°C. Upon achieving this target (reaction) temperature, the pressure was increased to the target value, marking the starting point for the reaction time of 2 hours. The reaction mixture was allowed to stir under these conditions of pressure and temperature for this reaction time, after which the reaction mixture was cooled to below 80°C and depressurized. The reaction mixture was then filtered to remove solids, and vial samples were submitted for composition analysis by gas chromatography-mass spectrometry (GC-MS).
- GC-MS gas chromatography-mass spectrometry
- a sixth experiment was conducted according to the procedures described in Example 1, except that the reaction temperature was l80°C, and 4.64 grams of a solid, carbon-supported ruthenium hydrogenation catalyst (5 wt-% Ru, BASF) was used, providing 2.5 mol-% Ru, relative to the gluconic acid substrate (assuming 50 wt-% moisture content of the catalyst). Also, an additive of 0.25 grams of ammonium acetate, or 7 mol-% relative to the substrate, was included in the initial reaction mixture.
- aspects of the invention relate to the use of synthesis methods described herein to produce a-amino acids and/or a-amino acids derivatives from readily available, or easily derived, substrates.
- the methods may advantageously address various shortcomings of conventional methods.
- Those having skill in the art, with the knowledge gained from the present disclosure, will recognize that various changes can be made to these processes in attaining these and other advantages, without departing from the scope of the present disclosure.
- the features of the disclosure are susceptible to modifications and/or substitutions without departing from the scope of this disclosure.
- the specific embodiments illustrated and described herein are for illustrative purposes only, and not limiting of the invention as set forth in the appended claims.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22176264.4A EP4140577A1 (de) | 2018-04-13 | 2019-04-02 | Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862657404P | 2018-04-13 | 2018-04-13 | |
PCT/US2019/025281 WO2019199518A1 (en) | 2018-04-13 | 2019-04-02 | Dehydration and amination of alpha-, beta-dihydroxy carbonyl compounds to alpha-amino acids |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22176264.4A Division EP4140577A1 (de) | 2018-04-13 | 2019-04-02 | Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3774720A1 true EP3774720A1 (de) | 2021-02-17 |
EP3774720A4 EP3774720A4 (de) | 2021-06-16 |
EP3774720B1 EP3774720B1 (de) | 2022-06-01 |
Family
ID=68162987
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22176264.4A Withdrawn EP4140577A1 (de) | 2018-04-13 | 2019-04-02 | Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren |
EP19785180.1A Active EP3774720B1 (de) | 2018-04-13 | 2019-04-02 | Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP22176264.4A Withdrawn EP4140577A1 (de) | 2018-04-13 | 2019-04-02 | Dehydratisierung und aminierung von alpha-, beta-dihydroxycarbonylverbindungen zu alpha-aminosäuren |
Country Status (11)
Country | Link |
---|---|
US (1) | US11414376B2 (de) |
EP (2) | EP4140577A1 (de) |
JP (1) | JP7098749B2 (de) |
CN (1) | CN111971270B (de) |
AU (1) | AU2019253285B2 (de) |
BR (1) | BR112020020664B1 (de) |
CA (1) | CA3096385C (de) |
DK (1) | DK3774720T3 (de) |
ES (1) | ES2922418T3 (de) |
MX (1) | MX2020010831A (de) |
WO (1) | WO2019199518A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11858874B2 (en) | 2020-12-21 | 2024-01-02 | Lg Chem, Ltd. | Method for preparing alpha-methylstyrene |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3762980B2 (ja) * | 2000-11-17 | 2006-04-05 | 独立行政法人産業技術総合研究所 | アミノ基導入法及びアミノ酸の合成方法 |
US9512061B2 (en) | 2011-12-19 | 2016-12-06 | Basf Se | Process for the preparation of racemic alpha-amino acids |
WO2014187712A1 (de) * | 2013-05-24 | 2014-11-27 | Basf Se | Verfahren zur herstellung von aminosäuren |
CN104803841B (zh) * | 2014-01-24 | 2017-03-01 | 中国科学院青岛生物能源与过程研究所 | 一种制备丙酮酸的方法 |
WO2017009047A1 (en) * | 2015-07-13 | 2017-01-19 | Evonik Degussa Gmbh | Method for producing l-methionine |
-
2019
- 2019-04-02 US US17/046,730 patent/US11414376B2/en active Active
- 2019-04-02 BR BR112020020664-4A patent/BR112020020664B1/pt active IP Right Grant
- 2019-04-02 EP EP22176264.4A patent/EP4140577A1/de not_active Withdrawn
- 2019-04-02 ES ES19785180T patent/ES2922418T3/es active Active
- 2019-04-02 AU AU2019253285A patent/AU2019253285B2/en active Active
- 2019-04-02 EP EP19785180.1A patent/EP3774720B1/de active Active
- 2019-04-02 CN CN201980025531.7A patent/CN111971270B/zh active Active
- 2019-04-02 JP JP2020555389A patent/JP7098749B2/ja active Active
- 2019-04-02 WO PCT/US2019/025281 patent/WO2019199518A1/en active Application Filing
- 2019-04-02 DK DK19785180.1T patent/DK3774720T3/da active
- 2019-04-02 MX MX2020010831A patent/MX2020010831A/es unknown
- 2019-04-02 CA CA3096385A patent/CA3096385C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN111971270A (zh) | 2020-11-20 |
MX2020010831A (es) | 2020-10-28 |
AU2019253285B2 (en) | 2023-03-09 |
BR112020020664A2 (pt) | 2021-01-12 |
JP2021521161A (ja) | 2021-08-26 |
US11414376B2 (en) | 2022-08-16 |
CA3096385C (en) | 2023-01-03 |
EP3774720A4 (de) | 2021-06-16 |
DK3774720T3 (da) | 2022-07-11 |
WO2019199518A1 (en) | 2019-10-17 |
BR112020020664B1 (pt) | 2022-08-02 |
CN111971270B (zh) | 2024-02-02 |
AU2019253285A1 (en) | 2020-10-29 |
EP3774720B1 (de) | 2022-06-01 |
JP7098749B2 (ja) | 2022-07-11 |
ES2922418T3 (es) | 2022-09-14 |
EP4140577A1 (de) | 2023-03-01 |
US20210163400A1 (en) | 2021-06-03 |
CA3096385A1 (en) | 2019-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2024319B1 (de) | Verfahren zur umwandlung von glycerol in propylenglycol und aminoalkohole | |
US20070287865A1 (en) | Process for the conversion of glycerol to propylene glycol and amino alcohols | |
AU2019253285B2 (en) | Dehydration and amination of alpha-, beta-dihydroxy carbonyl compounds to alpha-amino acids | |
HUE034834T2 (en) | Procedure for Pregabalin Production and Intermediates | |
JP2007522163A (ja) | 光学活性アルコールまたはカルボン酸の製造方法 | |
EP3774712B1 (de) | Dehydratisierung und spaltung von alpha-, beta-dihydroxycarbonylverbindungen zu milchsäure und anderen produkten | |
RU2785876C2 (ru) | Дегидратация и аминирование альфа-, бета-дигидроксикарбонильных соединений до альфа-аминокислот | |
WO2014016491A1 (fr) | Synthese de methyl propane diol a partir d'alcool allylique | |
CN114950505A (zh) | 一种用于氧化苯乙烯加氢制备β-苯乙醇的催化剂及其制备方法和应用 | |
RU2801218C2 (ru) | Дегидратация и расщепление альфа-, бета-дигидроксикарбонильных соединений до молочной кислоты и других продуктов | |
CN107001215A (zh) | 3‑丁烯‑1,2‑二醇(bdo)的催化氧化反应 | |
JP2918696B2 (ja) | アミノ酸の製造方法 | |
Groehn et al. | Stereoselective Hydrogenation of Folic Acid Dimethyl Ester Benzenesulfonate: A New Access to Optically Pure l‐Tetrahydrofolic Acid | |
JP2022117206A (ja) | エステルの製造方法 | |
JP2024504619A (ja) | カルボン酸の製造方法 | |
JP6806716B2 (ja) | 2,4−ジヒドロキシ酪酸の製造方法 | |
CN113845454A (zh) | 一种酮基蛋氨酸及其衍生物的制备方法及应用 | |
JPS58164555A (ja) | ヒドロキシアミノ酪酸の製法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20201105 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20210517 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07C 45/66 20060101ALI20210510BHEP Ipc: C07C 221/00 20060101AFI20210510BHEP Ipc: C07C 225/06 20060101ALI20210510BHEP Ipc: C07C 49/24 20060101ALI20210510BHEP Ipc: C07C 49/12 20060101ALI20210510BHEP Ipc: B01J 23/30 20060101ALI20210510BHEP Ipc: B01J 23/46 20060101ALI20210510BHEP Ipc: B01J 21/18 20060101ALI20210510BHEP Ipc: B01J 23/652 20060101ALI20210510BHEP Ipc: C07C 213/02 20060101ALI20210510BHEP Ipc: C07C 227/08 20060101ALI20210510BHEP Ipc: C07C 227/18 20060101ALI20210510BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20211217 |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MA, CHI CHENG Inventor name: ROGNESS, DONALD Inventor name: BRAZDIL, JAMES |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1495310 Country of ref document: AT Kind code of ref document: T Effective date: 20220615 Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602019015482 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: FI Ref legal event code: FGE |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20220704 |
|
REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2922418 Country of ref document: ES Kind code of ref document: T3 Effective date: 20220914 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220901 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220902 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220901 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1495310 Country of ref document: AT Kind code of ref document: T Effective date: 20220601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221003 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20221001 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602019015482 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20230302 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230531 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230402 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20220601 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230430 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230402 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240320 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230402 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FI Payment date: 20240320 Year of fee payment: 6 Ref country code: GB Payment date: 20240321 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20240320 Year of fee payment: 6 Ref country code: IT Payment date: 20240320 Year of fee payment: 6 Ref country code: FR Payment date: 20240320 Year of fee payment: 6 Ref country code: DK Payment date: 20240320 Year of fee payment: 6 Ref country code: BE Payment date: 20240320 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240320 Year of fee payment: 6 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20240502 Year of fee payment: 6 |